Expect EPS upgrades valuation rerating for Aurobindo: Surajit Pal News News / News 6 years ago 471 Views comments Aurobindo Pharma has gotten the United States Foods and Drug Administration (USFDA) approval for a generic drug that treats a chronic kidney disease.... Read more
News Buy Indiabulls Housing Finance, Exide Industries, Tech Mahindra: Sudarshan Sukhani News / News - 6 years ago
News Axis Bank Q2 profit seen up 307%; slippages from watchlist key to watch News / News - 6 years ago
News SC asks RBI, Centre if #39;genuine#39; cases can be given a window to deposit demonetised notes News / News - 6 years ago
Comments